PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Wuerzburg, Germany.\', \'Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\', \'Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.\', \'Royal Liverpool University Hospital, Liverpool, UK.\', \'Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/14651858.CD015017.pub2
?:doi
?:hasPublicationType
?:journal
  • The Cochrane database of systematic reviews
is ?:pmid of
?:pmid
?:pmid
  • 34318930
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Ivermectin for preventing and treating COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all